Dietary supplementation with L-arginine in patients with breast cancer (> 4 cm) receiving multimodality treatment: report of a feasibility study.

L-Arginine has been shown, in human breast cancers, to increase protein synthesis and the number of cells in the growth phase of the cell cycle. L-Arginine, therefore, may potentiate the response of breast cancers to cell cycle-specific cytotoxic agents. This phase II pilot study assessed the clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Brittenden, J., Heys, S. D., Miller, I., Sarkar, T. K., Hutcheon, A. W., Needham, G., Gilbert, F., McKean, M., Ah-See, A. K., Eremin, O.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1994
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968918/
https://www.ncbi.nlm.nih.gov/pubmed/8180024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968918/
https://www.ncbi.nlm.nih.gov/pubmed/8180024

Ejemplares similares